NOD-like Receptor (NLR)
Nucleotide oligomerization domain (NOD)-like receptors (NLRs) are a specialized group of intracellular proteins that play a critical role in the regulation of the host innate immune response. NLRs act as scaffolding proteins that assemble signaling platforms that trigger nuclear factor-κB and mitogen-activated protein kinase signaling pathways and control the activation of inflammatory caspases. Importantly, mutations in several members of the NLR family have been linked to a variety of inflammatory diseases consistent with these molecules playing an important role in host-pathogen interactions and the inflammatory response. NLRs including Nod1 and Nod2 are thought to be kept in an inactive state by intra-molecular interactions.
The central role of the Nod-like receptor (NLR) protein family became increasingly appreciated in innate immune responses. NLRs are classified as part of the signal transduction ATPases with numerous domains (STAND) clade within the AAA+ ATPase family.
Targets for NOD-like Receptor (NLR)
Products for NOD-like Receptor (NLR)
- Cat.No. Product Name Information
-
GC50569
NLRP3-IN-2
NLRP3 inflammasome inhibitor
-
GC70787
β-Aminoarteether
β-Aminoarteether (SM934 free base) is an Artemisinin derivative with orally active.
-
GC71405
ADS032
ADS032 is a dual inhibitor of NLRP1 and NLRP3 that can rapidly, reversibly and stably inhibit inflammasome formation.
-
GC72081
Antcin A
Antcin A is a potent NLRP3 inhibitor that inhibits the assembly and activation of the NLRP3 inflammasome.
-
GC35385
Arglabin
A sesquiterpene lactone
-
GC62507
BMS-986299
BMS-986299 (compound 112) is a first-in-class NLRP3 inflammasome agonist with an EC50 of 1.28 μM.
-
GC38059
Cardamonin
A chalconoid with anti-inflammatory and anti-tumor activity
-
GC50342
CP 424174
Inhibitor of IL-1β post-translational processing; indirectly inhibits NLRP3
-
GC73796
CVN293
CVN293 is a selective and brain permeable potassium ion (K+) channel KCNK13 inhibtor with IC50s of 41 nM and 28 nM for hKCNK13 and mKCNK13, respectively.
-
GC19113
CY-09
CY-09, a specific inhibitor of the NLRP3 inflammasome, directly targets NLRP3 and has an IC50 value of 18.9, 8.18, >50, >50 and 26.0 uM for each of the five major cytochrome P450 enzymes.
-
GC34555
Dapansutrile
3-methanesulfonyl Propanenitrile
An NLRP3 inflammasome inhibitor -
GC69156
GDC-2394
GDC-2394 is an orally effective and selective NLRP3 inhibitor that also inhibits IL-1β, with IC50 values of 0.4 μM (human IL-1β) and 0.1 μM (mouse IL-1β). GDC-2394 inhibits caspase-1 activity induced by NLRP3, but does not inhibit inflammasome activation dependent on NLRC4.
-
GC60887
GSK717
GSK717 is a potent, selective NOD2 (nucleotide-binding oligomerization domain 2) inhibitor.
-
GC71351
HMGB1-IN-1
HMGB1-IN-1 (compound 6) displays strong NO inhibitory effect in RAW264.7 cells with IC50 value of 15.9 ± 0.6 μM.
-
GC74070
INF 195
INF 195 is an NLRP3 inhibitor.
-
GC19201
INF39
INF39 is an irreversible and noncytotoxic NLRP3 inhibitor.
-
GC60958
JC-171
JC-171 is a selective NLRP3 inflammasome inhibitor, with an IC50 of 8.45 μM for inhibiting LPS/ATP-induced interleukin-1β (IL-1β) release from J774A.1 macrophages.
-
GC62300
JC124
JC124 is a specific NLRP3 inflammasome inhibitor.
-
GC69311
JC2-11
JC2-11 is an inhibitor of inflammasomes. It inhibits the NLRP3, AIM2, and non-canonical (NC) inflammasomes that contain a recruitment domain protein. JC2-11 reduces the secretion of caspase-1 (p20), cleavage of gasdermin D (GSDMD), and release of IL-1β and lactate dehydrogenase (LDH) in inflammasomes. JC2-11 inhibits the activation of inflammasomes by disrupting the production of reactive oxygen species and the activity of caspase-1.
-
GC72284
M-TriDAP
M-TriDAP (N-Acetylmuramyl-L-Ala-γ-D-Glu-meso-diaminopimelic acid) is a NOD1/2 agoist and biological active peptide.
-
GC62454
MCC7840 sodium
MCC7840 sodium
Emlenoflast (MCC7840) sodium, a sulfonylurea, is a potent and selective inhibitor of NLRP3 inflammasome, with an IC50 of <100 nM. -
GC31644
MCC950 (CP-456773)
CP 456,773
MCC950 (CP-456773) (CP-456773; CRID3) is a potent and selective NLRP3 inhibitor with IC50s of 7.5 and 8.1 nM in BMDMs and HMDMs, respectively. -
GC10634
MCC950 sodium
CRID3 sodium salt
MCC950 is a potent, selective, small molecule inhibitor of NLRP3.
-
GC16641
ML130 (Nodinitib-1)
CID1088438, ML130
ML130 (Nodinitib-1) (ML130;CID-1088438) is a NOD1 inhibitor with an IC50 of 0.56 μM. -
GC50556
NBC 19
Potent NLRP3 inflammasome inhibitor
-
GC50611
NBC 6
NBC 6 is a potent, selective NLRP3 inflammasome inhibitor (IC50= 574 nM) that acts independently of Ca2+.
-
GC71149
NIC-0102
NIC-0102 is an orally active proteasome inhibitor (pIC50=7.55) that specifically inhibits NLRP3 inflammatory vesicle activation.
-
GC39719
Nigericin
K+/H+ ionophore,promoting K+/H+ exchange across mitochondrial membrane
-
GC15811
Nigericin sodium salt
NSC 292567
Nigericin sodium salt is an electrically neutral K +/H + ionophore from Streptomyctus hygroscopicus an antibiotic that is lipophilic and selectively causes potassium to drain from the mitochondrial membrane. -
GC69570
NLRP3-IN-10
NLRP3-IN-10 is a potent inhibitor of NLRP3 that inhibits IL-1β with an IC50 of 251.1 nM. NLRP3-IN-10 can reduce ASC speck formation and inhibit NLRP3 inflammasome activation.
-
GC69571
NLRP3-IN-11
NLRP3-IN-11 is an inhibitor of the NLRP3 protein. It has biological activity with an IC50 value of <0.3 μM. NLRP3-IN-11 can be used for research on inflammatory and degenerative diseases, including NASH, atherosclerosis and other cardiovascular diseases, Alzheimer's disease, Parkinson's disease, diabetes, gout and many other autoimmune inflammatory diseases.
-
GC69572
NLRP3-IN-13
NLRP3-IN-13 (compound C77 in reference patent) is an effective selective NLRP3 inhibitor (IC50: 2.1 μM). It inhibits NLRP3 and NLRC4 inflammasomes, and suppresses IL-1β production mediated by NLRP3. NLRP3-IN-13 also inhibits NLRP3 ATPase activity. It can be used for research on neuroinflammatory diseases.
-
GC71230
NLRP3-IN-17
NLRP3-IN-17 is a potent, selective and orally active NLRP3 inflammasome inhibitor with an IC50 value of 7 nM.
-
GC69573
NLRP3-IN-18
NLRP3-IN-18 (compound 13) is an effective NLRP3 inhibitor with an IC50 value of ≤ 1.0 µM[1].
-
GC69569
NLRP3/AIM2-IN-2
NLRP3/AIM2-IN-2 is a novel potent inhibitor with species-specific effects on NLRP3 and AIM2 inflammasome-dependent cell pyroptosis, with an IC50 value of 0.2392 ±0.0233μM.
-
GC31657
NOD-IN-1
An inhibitor of NOD1 and NOD2
-
GC65995
NOD2 antagonist 1
NOD2 antagonist 1 (compound 32) is a potent and selective NOD2 antagonist with an IC50 of 5.23 μM. NOD2 antagonist 1 inhibits Muramyl dipeptide (MDP)-induced IL-8 secretion in THP-1 cells and inhibits MDP-induced IL-6, IL-10, TNF-α release in PBMCs.
-
GC71499
NP3-562
NP3-562 is a potent, orally active, tricyclic NLRP3 Inhibitor, with an IC50 of 214 nM.
-
GC73942
NT-0249 free base
NT-0249 free base is an orally active NLRP3 inhibitor.
-
GC73644
NT-0796
NT-0796 is an orally active, selective and CNS-penetrant NLRP3 inflammasome inhibitor.
-
GC74298
Oxidized low density lipoprotein (Human)
Human ox-LDL
Oxidized low density lipoprotein (Human) (Human ox-LDL) is involved in atherogenesis.
-
GC72139
Peptide5 TFA
Peptide5 TFA, a connexin 43 mimetic peptide, reduces animals swelling, astrogliosis, and neuronal cell death after spinal cord injury.
-
GC63377
QS-21
QS-21 is an immune-stimulatory saponin that can be used as an effective vaccine adjuvant.
-
GN10172
Ruscogenin
-
GC64089
Selnoflast
Selnoflast (example 6) is a NLRP3 inhibitor (extracted from patent WO2019008025).
-
GC61284
Soyasaponin II
Soyasaponin II is a saponin with antiviral activity.
-
GC40928
Trimethylamine N-oxide
TMAO
Trimethylamine N-oxide (TMAO) is a product of the oxidation of TMA by flavin-containing mono-oxygenase 3 in the liver. -
GC15933
Troxerutin
Trihydroxyethylrutin, Vitamin P4
flavonoid -
GC71396
Usnoflast
Usnoflast is a NLRP3 modulator, as well as a non-steroidal anti-inflammatory agent (NSAD).
-
GC39311
YQ128
YQ128 is a potent and selective second-generation NLRP3 (NOD-like receptor P3) inflammasome inhibitor with an IC50 of 0.30 ?M.